CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $532.48 | $21K | 333,583 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $534.63 | $128K | 333,343 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $535.89 | $214K | 332,943 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −633 | $537.19 | $340K | 332,310 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,127 | $538.00 | $606K | 331,183 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −525 | $539.09 | $283K | 330,658 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,002 | $540.23 | $1.1M | 328,656 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,930 | $541.20 | $1.0M | 326,726 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −883 | $542.07 | $479K | 325,843 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $543.15 | $217K | 325,443 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −480 | $544.35 | $261K | 324,963 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −480 | $545.48 | $262K | 324,483 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $546.00 | $22K | 324,443 |
| 2026-10-14 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 233,410 | ||
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −639 | $542.76 | $347K | 333,304 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,340 | $543.48 | $1.3M | 330,964 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,492 | $544.56 | $812K | 329,472 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,507 | $545.52 | $822K | 327,965 |
| 2026-10-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,452 | $546.46 | $793K | 326,513 |
Page 19 of 120 · 2,391 trades